Obesity and COVID-19: what makes obese host so vulnerable?
Sameer MohammadRafia AzizSaeed Al MahriShuja Shafi MalikEsraa HajiAltaf Husain KhanTanvir Saleem KhatlaniAbderrezak BouchamaPublished in: Immunity & ageing : I & A (2021)
The disease (COVID-19) novel coronavirus pandemic has so far infected millions resulting in the death of over a million people as of Oct 2020. More than 90% of those infected with COVID-19 show mild or no symptoms but the rest of the infected cases show severe symptoms resulting in significant mortality. Age has emerged as a major factor to predict the severity of the disease and mortality rates are significantly higher in elderly patients. Besides, patients with underlying conditions like Type 2 diabetes, cardiovascular diseases, hypertension, and cancer have an increased risk of severe disease and death due to COVID-19 infection. Obesity has emerged as a novel risk factor for hospitalization and death due to COVID-19. Several independent studies have observed that people with obesity are at a greater risk of severe disease and death due to COVID-19. Here we review the published data related to obesity and overweight to assess the possible risk and outcome in Covid-19 patients based on their body weight. Besides, we explore how the obese host provides a unique microenvironment for disease pathogenesis, resulting in increased severity of the disease and poor outcome.
Keyphrases
- coronavirus disease
- sars cov
- type diabetes
- weight loss
- metabolic syndrome
- insulin resistance
- weight gain
- cardiovascular disease
- body weight
- adipose tissue
- systematic review
- stem cells
- early onset
- coronary artery disease
- physical activity
- body mass index
- optical coherence tomography
- artificial intelligence
- drug induced
- lymph node metastasis